{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Zeng Y"],"funding":["Medical Science and Technology Research Foundation of Guangdong Province","Startup Foundation for Doctor Talents of Ganzhou People's Hospital","Startup Foundation for Doctor Talents of Ganzhou People's Hospital"],"pagination":["1052-1060"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12502934"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["46(11)"],"pubmed_abstract":["Objective
To assess the diagnostic value of fluorine 18 ( 18 F)-labeled prostate-specific membrane antigen (PSMA)-1007 PET/MRI and compare with that of 18 F-PSMA-1007 PET/computed tomography (CT) for biochemical recurrence (BCR) of prostate cancer (PCa) after radical prostatectomy.Materials and methods
We enrolled 40 patients who underwent 18 F-PSMA-1007 PET/CT and 18 F-PSMA-1007 PET/MRI for BCR after radical prostatectomy. Two readers independently assessed the images and determined their overall assessment of positive lesions on PET/MRI and PET/CT. The association between the patients' clinical characteristics and positive detection results on the PET/CT and PET/MRI was explored. The PET/CT and PET/MRI results were verified during a 24-month follow-up to calculate their d"],"journal":["Nuclear medicine communications"],"pubmed_title":["Diagnostic value of 18 F-prostate-specific membrane antigen-1007 PET/MRI versus 18 F-prostate-specific membrane antigen-1007 PET/computed tomography for biochemical recurrence of prostate cancer after radical prostatectomy."],"pmcid":["PMC12502934"],"funding_grant_id":["2024040022","A2024144"],"pubmed_authors":["Liao H","Jiang G","Zeng Y","Wu G","Zhong J"],"additional_accession":[]},"is_claimable":false,"name":"Diagnostic value of 18 F-prostate-specific membrane antigen-1007 PET/MRI versus 18 F-prostate-specific membrane antigen-1007 PET/computed tomography for biochemical recurrence of prostate cancer after radical prostatectomy.","description":"Objective
To assess the diagnostic value of fluorine 18 ( 18 F)-labeled prostate-specific membrane antigen (PSMA)-1007 PET/MRI and compare with that of 18 F-PSMA-1007 PET/computed tomography (CT) for biochemical recurrence (BCR) of prostate cancer (PCa) after radical prostatectomy.Materials and methods
We enrolled 40 patients who underwent 18 F-PSMA-1007 PET/CT and 18 F-PSMA-1007 PET/MRI for BCR after radical prostatectomy. Two readers independently assessed the images and determined their overall assessment of positive lesions on PET/MRI and PET/CT. The association between the patients' clinical characteristics and positive detection results on the PET/CT and PET/MRI was explored. The PET/CT and PET/MRI results were verified during a 24-month follow-up to calculate their d","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Nov","modification":"2026-06-04T06:22:25.028Z","creation":"2026-05-06T03:12:56.164Z"},"accession":"S-EPMC12502934","cross_references":{"pubmed":["40660863"],"doi":["10.1097/MNM.0000000000002028"]}}